259 related articles for article (PubMed ID: 33126356)
21. Anaplastic multiple myeloma: possible limitations of conventional chemotherapy for long-term remission.
Ichikawa S; Fukuhara N; Hatta S; Himuro M; Nasu K; Ono K; Okitsu Y; Kobayashi M; Onishi Y; Ri M; Ichinohasama R; Harigae H
J Clin Exp Hematop; 2018; 58(1):39-42. PubMed ID: 29553093
[No Abstract] [Full Text] [Related]
22. Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients.
Pejša V; Prka Ž; Lucijanić M; Mitrović Z; Piršić M; Jakšić O; Ajduković R; Kušec R
Croat Med J; 2017 Feb; 58(1):40-48. PubMed ID: 28252874
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Zinzani PL; Martelli M; Magagnoli M; Zaccaria A; Ronconi F; Cantonetti M; Bocchia M; Marra R; Gobbi M; Falini B; Gherlinzoni F; Moretti L; De Renzo A; Mazza P; Pavone E; Sabattini E; Amendola A; Bendandi M; Pileri SA; Mandelli F; Tura S
Blood; 1998 Aug; 92(3):790-4. PubMed ID: 9680346
[TBL] [Abstract][Full Text] [Related]
24. Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma.
Foyil KV; Kennedy DA; Grove LE; Bartlett NL; Cashen AF
Leuk Lymphoma; 2012 Mar; 53(3):506-7. PubMed ID: 21867368
[No Abstract] [Full Text] [Related]
25. [Clinical features and prognosis for anaplastic large cell lymphoma].
Dong F; Liu Y; Li Q; Wang J; Jing H; Ke X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 43(6):631-637. PubMed ID: 30110005
[TBL] [Abstract][Full Text] [Related]
26. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
27. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.
Zinzani PL; Bendandi M; Martelli M; Falini B; Sabattini E; Amadori S; Gherlinzoni F; Martelli MF; Mandelli F; Tura S; Pileri SA
J Clin Oncol; 1996 Mar; 14(3):955-62. PubMed ID: 8622045
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin's lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy.
Hanna F; Prakash A; Allan E; Khalafallah AA
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29549134
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female.
Patzelt M; Zarubova L; Klener P; Barta J; Benkova K; Brandejsova A; Trneny M; Gürlich R; Sukop A
Aesthetic Plast Surg; 2018 Apr; 42(2):451-455. PubMed ID: 29101436
[TBL] [Abstract][Full Text] [Related]
31. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
32. Treatment of AIDS-associated anaplastic large-cell lymphoma with dose-adjusted EPOCH chemotherapy.
Nagajothi N; Dham SK; Gelfand Y; Sanmugarajah J
J Natl Med Assoc; 2007 Jul; 99(7):799-801. PubMed ID: 17668647
[TBL] [Abstract][Full Text] [Related]
33. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
34. Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
Vitolo U; Cortellazzo S; Liberati AM; Freilone R; Falda M; Bertini M; Botto B; Cinieri S; Levis A; Locatelli F; Lovisone E; Marmont F; Pizzuti M; Rossi A; Viero P; Barbui T; Grignani F; Resegotti L
J Clin Oncol; 1997 Feb; 15(2):491-8. PubMed ID: 9053470
[TBL] [Abstract][Full Text] [Related]
35. Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Dawn G; Morrison A; Morton R; Bilsland D; Jackson R
Clin Exp Dermatol; 2003 Nov; 28(6):620-4. PubMed ID: 14616830
[TBL] [Abstract][Full Text] [Related]
36. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
[TBL] [Abstract][Full Text] [Related]
37. The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
Dreger P; Martin S; Kuse R; Sonnen R; Glass B; Kröger N; Parwaresch R; Kneba M; Schmitz N; Haas R
Hematol J; 2000; 1(2):87-94. PubMed ID: 11920175
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
39. Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Tian C; Chen Z; Li Y
J Int Med Res; 2020 Jul; 48(7):300060520936053. PubMed ID: 32643971
[TBL] [Abstract][Full Text] [Related]
40. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
